As genetic engineering remains a controversial public opinion topic, they are till today not allowed by EFSA to be commercialized within the EU.
As genetic engineering is a controversial public opinion topic, commerciallisation remains difficult. In March 2010, EFSA allowed Amflora to be commercialized within the EU.